The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: A randomized, double-blind, clinical trial

International Journal of Dermatology

Volumn 53, Issue 1, 2014, Pages 100-108

  Evangelista, Mara Therese Padilla ^a   Abad Casintahan, Flordeliz ^a   Lopez Villafuerte, Lillian ^a  

^a Jose R Reyes Memorial Medical Center   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

COCONUT OIL; MINERAL OIL; UNCLASSIFIED DRUG; VIRGIN COCONUT OIL;

ARTICLE; ATOPIC DERMATITIS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HEMODYNAMICS; HUMAN; HYDRATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORAD INDEX; SCORING SYSTEM; SKIN CAPACITANCE; SKIN WATER LOSS; STRATUM CORNEUM; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; ELECTRIC CAPACITANCE; EPIDERMIS; FEMALE; HUMANS; INFANT; MALE; MINERAL OIL; PLANT OILS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84890801839     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12339     Document Type: Article

References (40)

1. Williams HC. Atopic dermatitis. N Engl J Med 2005; 352: 2314-2324.
2. Johnson AW. Overview: fundamental skin care - protecting the barrier. Dermatol Ther 2004; 17: 1-5.
3. Seidenari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 1995; 75: 429-433.
4. Chamlin SL, Frieden IJ, Fowler A, et al. Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis. Arch Dermatol 2001; 137: 1110-1112.
5. Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002; 47: 198-208.
6. Watanabe M, Tagami H, Horii I, et al. Functional analyses of the superficial stratum corneum in atopic xerosis. Arch Dermatol 1991; 127: 1689-1692.
7. Tanaka M, Okada M, Zhen YX, et al. Decreased hydration state of the stratum corneum and reduced amino acid content of the skin surface in patients with seasonal allergic rhinitis. Br J Dermatol 1998; 139: 618-621.
8. Horii I, Nakayama Y, Obata M, et al. Stratum corneum hydration and amino acid content in xerotic skin. Br J Dermatol 1989; 121: 587-592.
9. Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics 2008; 122: 812-824.
10. Simpson EL, Berry TM, Brown PA, et al. A pilot study of emollient therapy prevention of atopic dermatitis. J Am Acad Dermatol 2010; 63: 587-593.
11. Eichenfield LF, Hanifin JM, Luger TA, et al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 2003; 49: 1088-1095.
12. Loden M. The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol 2005; 19: 672-688.
13. Nicholls S, King CS, Marks R. Short-term effect of emollients and a bath oil on the stratum corneum. J Soc Cosmet Chem 1978; 29: 617-624.
14. Wolff K, Goldsmith LA, Katz SI, et al., eds. Fitzpatrick's Dermatology in General Medicine, Vol II, 7th edn. New York, NY: McGraw Hill, 2008.
15. Agero AL, Verallo-Rowell VM. A randomized double-blind controlled trial comparing extra-virgin coconut oil with mineral oil as a moisturizer for mild to moderate xerosis. Dermatitis 2004; 15: 109-116.
16. Verallo-Rowell VM, Dillague KM, Syah-Tjundawan BS. Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis. Dermatitis 2008; 19: 308-315.
17. Sushma N, Vinod P, Deepak C, et al. Topical coconut oil application reduces transepidermal loss in preterm very low birth weight neonates: a randomized clinical trial. Pediatrics 2008; 121: 139.
18. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112(Suppl. 6): 118-127.
19. Lewis-Jones S, Mugglestone MA. Management of atopic eczema in children aged up to 12 years: summary of NICE guidance. BMJ 2007; 335: 1263.
20. Kunz B, Oranje AP, Labrèze LJ, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997; 195: 10-19.
21. Gruber C, Wendt M, Sulser C, et al. Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 2007; 62: 1270-1276.
22. Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomized controlled trial. Lancet 2006; 367: 839-846.
23. Heinlin J, Schiffner-Rohe J, Schiffner R, et al. A first prospective randomized controlled trial on the efficacy and safety of synchronous balneophototherapy vs. narrow-band UVB monotherapy for atopic dermatitis. J Eur Acad Dermatol Venereol 2010; 25: 765-773.
24. Sugarman JL, Parish LC. Efficacy of a lipid-based barrier repair formulation in moderate to severe pediatric atopic dermatitis. J Drugs Dermatol 2009; 8: 1106-1111.
25. Meurer M, et al. CASM-DE-01 Study Group. Longterm efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology 2004; 208: 365-372.
26. Meurer M, et al. CASM-DE-01 Study Group. Pimecrolimus cream in the longterm management of atopic dermatitis in adults: a six-month study. Dermatology 2002; 205: 271-277.
27. Hon KL, et al. Lesson from performing SCORADs in children with atopic dermatitis: subjective symptoms do not correlate well with disease extent or intensity. Int J Dermatol 2006; 45: 728-730.
28. Schliemann-Willers S, Wigger-Alberti W, et al. Natural vegetable fats in the prevention of irritant contact dermatitis. Contact Dermatitis 2002; 46: 6-12.
29. Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991; 24: 1-26.
30. Escobar SO, Achenbach R, Innantuono R, et al. Topical fish oil in psoriasis - a controlled and blind study. Clin Exp Dermatol 1992; 17: 159-162.
31. Tollesson A, Frithz A. Borage oil, an effective new treatment for infantile seborrhoeic dermatitis. Br J Dermatol 1993; 129: 95.
32. Zatz JL. Scratching the surface: skin permeation. Cosmet Toil 1990; 105: 39-50.
33. Kapoor S, Saraf S. Assessment of viscoelasticity and hydration effect of herbal moisturizers using bioengineering techniques. Pharmacogn Mag 2010; 6: 298-304.
34. Intahphuak S, Khonsung P, Panthong A. Anti-inflammatory, analgesic, and antipyretic activities of virgin coconut oil. Pharm Biol 2010; 48: 151-157.
35. Marina AM, Man YB, Nazimah SA, et al. Antioxidant capacity and phenolic acids of virgin coconut oil. Int J Food Sci Nutr 2009; 60(Suppl. 2): 114-123.
36. Buraczewska I, Berne B, Lindberg M, et al. Changes in skin barrier function following longterm treatment with moisturizers, a randomized controlled trial. Br J Dermatol 2007; 156: 492-498.
37. Kamo A, Tominaga M, Negi O, et al. Topical application of emollients prevents dry skin-inducible intraepidermal nerve growth in acetone-treated mice. J Dermatol Sci 2011; 62: 64-66.
38. Bergsson G, Arnfinnsson J, Steingrimsson O, et al. Killing of gram-positive cocci by fatty acids and monoglycerides. APMIS 2001; 9: 670-678.
39. Rietschel RL, Fowler JF, Fisher AA. Fisher's Contact Dermatitis, 6th edn. Shelton, CT: People's Medical Publishing House, 2008.
40. Nevin KG, Rajamohan T. Wet and dry extraction of coconut oil: impact on lipid metabolic and antioxidant status in cholesterol coadministered rats. Can J Physiol Pharmacol 2009; 87: 610-616.